Attention Amgen: Canada OKs Samsung Bioepis and Merck's Enbrel biosimilar 12-Sep-2016 By Dan Stanton Canada has approved Brenzys, its first biosimilar version of Amgen’s Enbrel (etanercept) made by Korean drugmaker Samsung Bioepis.
Europe OKs Samsung Bioepis’ Remicade biosimilar Flixabi 31-May-2016 By Gareth Macdonald The European Commission (EC) has approved Samsung Bioepis’ Remicade (infliximab) biosimilar.